Summary

The telehealth and telemdicine market is projected to reach USD 180.86 billion by 2030 from USD 94.14 billion in 2024, at a CAGR of 11.5% from 2024 to 2030. The telehealth and telemedicine market is rapidly expanding due to a variety of factors such as advancement in telecommunication technologies, government support and regulatory policies, and expansion of remote patient moniytoring systems. An aging population necessitates continuous monitoring of chronic conditions, creating a growing demand for cost-effective healthcare solutions. Furthermore, the rising prevalence of chronic diseases, such as diabetes and cardiovascular disease, emphasizes the value of remote care. Telemedicine saves a lot of time and money, hence becoming attractive for both patients and providers. The advancements in the field of telecommunications technology along with the increasing adoption of remote patient monitored technologies have enhanced the virtual care success rate and market adoption, while government support through favorable regulation and reimbursable frameworks has helped in market expansion.
“Patients segment had the fastest growth rate in the telehealth & telemedicine market during the forecast period, by end user.”
By end user, the patients segment is the fastest growing segment in the telehealth and telemedicine market during the forecast period. This is mainly due to the growing adoption of remote healthcare services, which enable patients to receive medical consultations and treatment from the comfort of their own homes. The factors that have contributed to the increase include growing chronic conditions, the need for convenient and timely medical care, and the increasing awareness of the benefits of telemedicine. The COVID-19 pandemic had also been an accelerator of telehealth, with patients seeking safer alternatives to in-person visits. Other factors that are driving this market segment include enhanced patient comfort, reduced healthcare costs, and improved access to specialists, especially in rural or underserved areas.
“By component, software segment to accounted for the largest market share in the telehealth and telemedicine market.”
Based on component, the software segment accounted for the largest market share in the telehealth and telemedicine market. This is due to the increase in the use of telehealth platforms for virtual consultation, remote patient monitoring, and electronic health record management. With use of digital resources by healthcare providers becoming widespread in delivering care in an efficient manner, software for video conferencing, appointment scheduling, secure messaging and data analytics, are fast becoming critical. The integration of artificial intelligence (AI) and machine learning in telemedicine application software also is accelerateing market expansion, providing enhanced diagnostic capabilities, tailored clinical management, and better outcomes for the patient. Moreover, the rising focus on seamless interoperability between healthcare systems and regulatory compliance for data security and privacy further accelerates the demand for advanced telehealth software.
“Asia Pacific is estimated to register the fastest CAGR over the forecast period.”
The telehealth & telemdicine market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific telehealth & telemdicine market is projected to register fastest CAGR during the forecast period. The Asia Pacific is benefiting from the fast-developing healthcare infrastructure, advances in digital technologies. It is due to multiple factors such as the rising use of digital healthcare products, healthcare needs resulting from large and ageing populations, as well as an increasing incidence of chronic diseases. Moreover, internet penetration and mobile penetration have broadened in areas such as India and China, which in turn have accelerated the growth in telehealth services. Government activities promoting telemedicine and improvements in digital health infrastructure also play a role in contributing to the growth of telehealth and telemedicine market.
Breakdown of supply-side primary interviews by company type, designation, and region:
• By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
• By Designation: Managers (40%), Directors (35%), and Others (25%)
• By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%) and Middle East & Africa (2%)
List of Companies Profiled in the Report:
1. Koninklijke Philips N.V. (Netherlands)
2. Medtronic (Ireland)
3. GE Healthcare (US)
4. Epic Systems Corporation (US)
5. Oracle (US)
6. Doximity, Inc. (US)
7. Teladoc Health, Inc. (US)
8. American Well (US)
9. Siemens Healthineers AG (Germany)
10. Cisco Systems Inc. (US)
11. Included Health, Inc. (Doctor on Demand, Inc.) (US)
12. AMC Health (US)
13. TeleSpecialists (US)
14. Walgreen Co. (US)
15. Caregility (US)
16. CVS Health (US)
17. EverNorth Health, Inc. (US)
18. Elation (US)
19. Iron Bow Healthcare Solutions (US)
20. ZoomCommunications, Inc. (US)
21. Timedoc Health (US)
22. Cerebral Inc. (US)
23. Kindbody (US)
24. Transcarent (US)
25. Caresimple, Inc. (US)
Research Coverage:
This research report categorizes the telehealth & telemedicine market by component (Hardware (Telehealth Kits, Carts, And Stations, Patient Monitoring Devices (Cardiac Monitoring Devices, Neurological Monitoring Devices, Respiratory Monitoring Devices, Blood Glucose Monitoring Devices, Fetal & Neonatal Monitoring Devices, Weight Monitoring Devices, Multiparameter Monitoring Devices, Pulse Oximeter Devices, Other Monitoring Devices)), Software (By Modality: EHR Centric, Non-EHR Centric, By Integration Type: Integrated Software, Standalone Software, By Type: Remote Patient Monitoring, Virtual Care Platforms (Real-Time Interaction, Store & Forward), Video Conferencing platforms, Virtual sitting & Nursing, By Deployment: On-premise model, Cloud-based model), and Services). By Function (Clinical Care Management (Including Teleconsultation & Follow-Up), Preventive Care Management, Diagnostics & Treatment, Remote Patient Monitoring/Patient Monitoring, Rehabilitation & Recovery, Administrative, Analytics & Reporting, Patient Engagement, Other Functions (Clinical Trials, Education, Training, and Others), By Application (Primary Care, Speciality Care (Teleradiology, Telecardiology, Teleneurology, Diabetes, Respiratory Disorders (COPD, Asthma, And Others), Hypertension, Teledermatology, Telestroke, Telepsychiatry (Mental Health), Others (Dental, Oncology, Obstetrics, Gynaecology, Ophthalmology, Metabolic Disorders, Immunology, Gastroenterology, Nephrology & Urology, Rare Disease, Infectious Diseases, And Others), TeleICU, Virtual Sitting & Nursing, Other Applications (Clinical Trials, Emergency & Urgent Care, General Wellness & Lifestyle Improvement, Occupational Health, and Others), By Age Group (Pediatrics, Adults, Geriatrics), By End User (Healthcare Providers (Hospitals, Ambulatory Surgical Centers, Ambulatory Care Centers, and Other Outpatient Settings, Long Term Care & Assisted Living Facilities, Home Healthcare, Other Healthcare Providers (Diagnostics & Imagining Centers, Rehabilitation Centers, Behavioural Health Centers, and Others), Healthcare Payers (Public Payers, Private Payers), Patients, Pharmaceutical & Biotechnology Companies, Medtech Companies, Other End Users (Medtech Companies, Academic Institutes, Research Centers, Government Organizations, and Others)) and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the telehealth & telemedicine market. A thorough analysis of the key industry players has been done to provide insights into their business overview, offerings, and key strategies such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the telehealth & telemedicine market. Competitive analysis of upcoming startups in the telehealth & telemedicine market ecosystem is covered in this report.
Reasons to Buy the Report
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall telehealth & telemedicine market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers: (Growing geriatric population and increasing need to expand healthcare access, Rising prevalence of chronic conditions, Demonstrated Time and Cost Savings, Advancements in telecommunication technologies, Shortage of skilled healthcare professionals, Government support & Regulatory policies, Expansion of Remote Patient Monitoring (RPM) systems), restraints (High investment costs and lack of IT expertise, Regulatory variations across regions, Behavioral reluctance to adopt new technologies, Rise in fraud and abuse within healthcare systems, Patient privacy and confidentiality, adhering to medical ethics), opportunities (Growing use of wearables, apps, and sensors for virtual care, Emergence of AI/ML, Increasing shift towards outpatient care models, High utility of telemedicine against infectious diseases and epidemics, Expansion of hospital-at-home initiatives, Demand for EMR-based telehealth, Rapid growth of mental health care), and challenges (Data security concerns, Limited data accessibility, Inability to maintain hygiene and cleanliness standards) influencing the growth of the telehealth & telemedicine market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the telehealth & telemedicine market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the telehealth & telemedicine market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the telehealth & telemedicine market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), etc. among others in telehealth & telemedicine market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 43
1.1 STUDY OBJECTIVES 43
1.2 MARKET DEFINITION 43
1.2.1 TELEHEALTH 43
1.2.2 TELEMEDICINE 43
1.3 STUDY SCOPE 44
1.3.1 MARKET SEGMENTATION & GEOGRAPHICAL SPREAD 44
1.3.2 INCLUSIONS & EXCLUSIONS 45
1.3.3 YEARS CONSIDERED 47
1.3.4 CURRENCY CONSIDERED 47
1.4 STAKEHOLDERS 47
1.5 SUMMARY OF CHANGES 48
2 RESEARCH METHODOLOGY 50
2.1 RESEARCH DATA 50
2.1.1 SECONDARY DATA 51
2.1.1.1 Key sources of secondary data 51
2.1.1.2 Key data from secondary sources 52
2.1.2 PRIMARY DATA 52
2.1.2.1 Key sources of primary data 53
2.1.2.2 Key objectives of primary research 53
2.1.2.3 Key data from primary sources 54
2.1.2.4 Insights from primary experts 55
2.2 RESEARCH APPROACH 56
2.3 MARKET SIZE ESTIMATION 56
2.3.1 REVENUE SHARE ANALYSIS (SUPPLY-SIDE ANALYSIS) 57
2.3.2 BOTTOM-UP APPROACH (END-USER ADOPTION) 58
2.3.3 TOP-DOWN APPROACH 59
2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 60
2.4 DATA TRIANGULATION 63
2.5 MARKET SHARE ESTIMATION 64
2.6 STUDY ASSUMPTIONS 64
2.7 RESEARCH LIMITATIONS 64
2.7.1 METHODOLOGY-RELATED LIMITATIONS 64
2.7.2 SCOPE-RELATED LIMITATIONS 65
2.8 RISK ASSESSMENT 65
3 EXECUTIVE SUMMARY 66
4 PREMIUM INSIGHTS 72
4.1 TELEHEALTH & TELEMEDICINE MARKET OVERVIEW 72
4.2 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER AND REGION 73
4.3 TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT 74
4.4 TELEHEALTH & TELEMEDICINE MARKET: DEVELOPED VS. EMERGING MARKETS 75
5 MARKET OVERVIEW 76
5.1 INTRODUCTION 76
5.2 MARKET DYNAMICS 76
5.2.1 DRIVERS 78
5.2.1.1 Growing geriatric population and increasing need for advanced healthcare infrastructure 78
5.2.1.2 Rising prevalence of chronic diseases 80
5.2.1.3 Reduced time and lower out-of-pocket costs 81
5.2.1.4 Advancements in telecommunication technologies 81
5.2.1.5 Shortage of skilled healthcare professionals 81
5.2.1.6 Increased government support and favorable regulatory policies 82
5.2.1.7 Expansion of remote patient monitoring systems 83
5.2.2 RESTRAINTS 84
5.2.2.1 High investment costs for B2B models and lack of IT expertise 84
5.2.2.2 State-to-state and inter-country regulatory variations 85
5.2.2.3 Behavioral reluctance to adopt new technologies 86
5.2.2.4 Rise in fraud and abuse in healthcare systems 86
5.2.2.5 Adherence to patient privacy, confidentiality, medical ethics 87
5.2.3 OPPORTUNITIES 87
5.2.3.1 Growing use of wearables, applications, and sensors for virtual care 87
5.2.3.2 Emergence of AI and ML 88
5.2.3.3 Increasing shift toward outpatient care models 88
5.2.3.4 High utility of telemedicine against infectious communicable diseases and epidemics 89
5.2.3.5 Expansion of hospital-at-home (HaH) initiatives 90
5.2.3.6 Demand for electronic medical record-based telehealth services 90
5.2.3.7 Rising incidence of mental illnesses and growing focus on
emotional well-being 90
5.2.4 CHALLENGES 91
5.2.4.1 Data security and confidentiality concerns 91
5.2.4.2 Limited data accessibility 95
5.2.4.3 Inability to maintain patient hygiene and cleanliness standards 95
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 95
5.4 INDUSTRY TRENDS 96
5.5 ECOSYSTEM ANALYSIS 100
5.6 VALUE CHAIN ANALYSIS 103
5.7 TECHNOLOGY ANALYSIS 105
5.7.1 KEY TECHNOLOGIES 105
5.7.1.1 Video conferencing and real-time communication platforms 105
5.7.1.2 AI and ML 105
5.7.1.3 Virtual assistants and chatbots 105
5.7.1.4 Voice recognition and natural language processing 106
5.7.1.5 EHR integration 106
5.7.1.6 Remote patient monitoring systems 106
5.7.2 COMPLEMENTARY TECHNOLOGIES 106
5.7.2.1 Edge computing 106
5.7.2.2 Cloud computing 107
5.7.2.3 Mobile health (mHealth) applications 107
5.7.2.4 Wearable devices, sensors, and IoT 107
5.7.3 ADJACENT TECHNOLOGIES 108
5.7.3.1 Digital therapeutics 108
5.7.3.2 Blockchain technology 108
5.7.3.3 Augmented reality and virtual reality 108
5.8 TARIFF AND REGULATORY ANALYSIS 109
5.8.1 TARIFF DATA ANALYSIS 109
5.8.1.1 Tariff data for HS code 9018 109
5.8.1.2 Tariff data for HS code 9021 110
5.8.1.3 Tariff data for HS code 9022 111
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112
5.8.3 REGULATORY STANDARDS 114
5.8.4 REGULATORY FRAMEWORK 114
5.9 TRADE ANALYSIS 117
5.9.1 TRADE DATA FOR HSN CODE 90189099 117
5.9.1.1 Top 10 importers for HSN code 90189099 117
5.9.1.2 Top 10 exporters for HSN code 90189099 118
5.9.2 TRADE DATA FOR HSN CODE 9021 118
5.9.2.1 Top 10 importers for HSN code 9021 118
5.9.2.2 Top 10 exporters for HSN code 9021 119
5.9.3 TRADE DATA FOR HSN CODE 9022 119
5.9.3.1 Top 10 importers for HSN code 9022 119
5.9.3.2 Top 10 exporters for HSN code 9022 120
5.10 PRICING ANALYSIS 120
5.10.1 INDICATIVE PRICING FOR TELEHEALTH & TELEMEDICINE SOLUTIONS,
BY COMPONENT, 2023 121
5.10.2 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES,
BY REGION, 2023 122
5.10.3 PRICING MODELS 123
 
5.11 PORTER’S FIVE FORCES ANALYSIS 123
5.11.1 THREAT OF NEW ENTRANTS 125
5.11.2 THREAT OF SUBSTITUTES 125
5.11.3 BARGAINING POWER OF BUYERS 125
5.11.4 BARGAINING POWER OF SUPPLIERS 125
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 126
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 126
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 126
5.12.2 KEY BUYING CRITERIA 127
5.13 PATENT ANALYSIS 128
5.13.1 PATENT PUBLICATION TRENDS FOR TELEHEALTH & TELEMEDICINE 128
5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 129
5.14 UNMET NEEDS & END-USER EXPECTATIONS 130
5.14.1 UNMET NEEDS 130
5.14.2 END-USER EXPECTATIONS 131
5.15 KEY CONFERENCES & EVENTS, 2025–2026 132
5.16 CASE STUDY ANALYSIS 134
5.16.1 TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA’S INTEGRATED SOLUTIONS 134
5.16.2 USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES 134
5.16.3 CONE HEALTH TO REVOLUTIONIZE TELEHEALTH FOR TRANSITION TO CAREGILITY'S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS 135
5.17 INVESTMENT & FUNDING SCENARIO 136
5.18 BUSINESS MODEL ANALYSIS 136
5.18.1 DIRECT-TO-PATIENT (D2P) MODEL 136
5.18.2 BUSINESS-TO-BUSINESS (B2B) MODEL 136
5.18.3 EMPLOYER-SPONSORED MODEL 137
5.18.4 SUBSCRIPTION-BASED MODEL 137
5.18.5 HYBRID TELEMEDICINE MODEL 137
5.18.6 PLATFORM-AS-A-SERVICE (PAAS) MODEL 137
5.18.7 VALUE-BASED CARE MODEL 138
5.19 IMPACT OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET 138
5.19.1 KEY USE CASES 139
5.19.2 MAJOR CASE STUDIES 140
5.19.2.1 AI to redefine treatment effectiveness and safety 140
5.19.2.2 AI-driven chatbots and telehealth to enhance mental health and chronic disease management 141
5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 142
5.19.3.1 Healthcare IT and EHR systems 142
5.19.3.2 Pharmaceuticals & drug discovery 142
5.19.3.3 Mental health tech 143
5.19.3.4 Healthcare analytics and insights 143
5.19.4 USER READINESS & IMPACT ASSESSMENT 143
5.19.4.1 User readiness 143
5.19.4.1.1 User A: Hospitals 143
5.19.4.1.2 User B: Ambulatory surgery centers 143
5.19.4.2 Impact assessment 143
5.19.4.2.1 User A: Hospitals 144
5.19.4.2.2 User B: Ambulatory surgery centers 144
5.20 REIMBURSEMENT SCENARIO ANALYSIS 144
6 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT 147
6.1 INTRODUCTION 148
6.2 HARDWARE 148
6.2.1 TELEHEALTH KITS, CARTS, AND STATIONS 149
6.2.1.1 Increased focus on streamlined workflows and quality of remote healthcare services to drive adoption 149
6.2.2 PATIENT MONITORING DEVICES 150
6.2.2.1 Cardiac monitoring devices 152
6.2.2.1.1 Cardiac monitoring telehealth devices to minimize need for frequent hospital visits and improve patient outcomes 152
6.2.2.2 Neurological monitoring devices 153
6.2.2.2.1 Focus on better neuro care with advanced telemedicine solutions to augment segment growth 153
6.2.2.3 Respiratory monitoring devices 154
6.2.2.3.1 Rising prevalence of respiratory diseases and demand for home-based healthcare to drive segment 154
6.2.2.4 Blood glucose monitoring devices 155
6.2.2.4.1 Increasing number of diabetic patients in low- and middle-income countries to augment need for remote monitoring 155
6.2.2.5 Fetal & neonatal monitoring devices 156
6.2.2.5.1 Focus on continuous and personalized care without frequent in-person visits to drive segment 156
6.2.2.6 Weight monitoring devices 157
6.2.2.6.1 Rising prevalence of obesity and increasing awareness about weight management to drive market 157
6.2.2.7 Multiparameter monitoring devices 158
6.2.2.7.1 Rise of home healthcare and increased demand for remote patient monitoring to propel segment growth 158
6.2.2.8 Pulse oximeter devices 158
6.2.2.8.1 Remote pulse oximeter devices to manage chronic respiratory conditions and help faster patient recovery 158
6.2.2.9 Other patient monitoring devices 159
 
6.3 SOFTWARE 160
6.3.1 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY 160
6.3.1.1 EHR-centric software 161
6.3.1.1.1 EHR-centric software to improve patient information accessibility and secure sharing across platforms 161
6.3.1.2 Non-EHR-centric software 162
6.3.1.2.1 Non-EHR-centric software to conduct virtual consultations and facilitate telehealth services without constraints 162
6.3.2 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE 162
6.3.2.1 Integrated software 163
6.3.2.1.1 Integrated software to streamline clinical workflow and promote better access to patient health data 163
6.3.2.2 Standalone software 164
6.3.2.2.1 Increased focus on flexibility and ease of usage to fuel adoption 164
6.3.3 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE 164
6.3.3.1 Remote patient monitoring platforms 165
6.3.3.1.1 Increased popularity of at-home chronic disease management among geriatric patients to aid market growth 165
6.3.3.2 Virtual care platforms 167
6.3.3.2.1 Real-time interaction platforms 167
6.3.3.2.1.1 Synchronous nature and better healthcare access to drive segment 167
6.3.3.2.2 Store & forward platforms 168
6.3.3.2.2.1 Easy monitoring of vital signs for long-term chronic care without physical presence to fuel segment growth 168
6.3.3.3 Video conferencing platforms 169
6.3.3.3.1 Need for collaborative and coordinated care for chronic patients to augment segment growth 169
6.3.3.4 Virtual sitting & nursing platforms 170
6.3.3.4.1 Reduced workload of on-site staff and prevention of costly hospital readmissions to boost segment growth 170
6.3.4 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT 171
6.3.4.1 On-premise deployment models 171
6.3.4.1.1 Enhanced control and safety of inventory data with better reuse of existing infrastructure to drive market 171
6.3.4.2 Cloud-based deployment models 172
6.3.4.2.1 Need to integrate information from disparate locations in real time for database registry to drive segment 172
6.4 SERVICES 173
6.4.1 COST-EFFECTIVENESS AND REDUCED STRAIN ON HEALTHCARE PROVIDERS TO DRIVE MARKET 173
 
7 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION 175
7.1 INTRODUCTION 176
7.2 CLINICAL CARE MANAGEMENT 176
7.2.1 FOCUS ON REAL-TIME CONSULTATIONS, PROACTIVE MONITORING,
AND FOLLOW-UP STRATEGIES TO DRIVE MARKET 176
7.3 PREVENTIVE CARE MANAGEMENT 177
7.3.1 PREVENTIVE CARE AMONG RURAL PATIENTS TO REDUCE DELAYED DIAGNOSIS AND IMPROVE PATIENT ENGAGEMENT 177
7.4 DIAGNOSTICS & TREATMENT 178
7.4.1 DIAGNOSIS & TREATMENT TO SUPPORT PROACTIVE CARE MANAGEMENT AND DEVELOP PERSONAL HEALTHCARE PLANS 178
7.5 REMOTE PATIENT MONITORING/PATIENT MONITORING 179
7.5.1 REMOTE PATIENT MONITORING TO REVOLUTIONIZE PATIENT CARE BY IMPROVING ACCESSIBILITY, EFFICIENCY, AND HEALTH OUTCOMES 179
7.6 REHABILITATION & RECOVERY 180
7.6.1 ADOPTION OF TELEREHABILITATION TO OVERCOME REGIONAL BARRIERS AND SUPPORT PATIENTS WITH MOBILITY CHALLENGES 180
7.7 ADMINISTRATIVE 181
7.7.1 EFFICIENT ADMINISTRATIVE TASKS TO ENHANCE WORKFLOW AND IMPROVE OPERATIONAL EFFICIENCY 181
7.8 ANALYTICS & REPORTING 182
7.8.1 ADVANCED DATA ANALYTICS & REPORTING TO SUPPORT PROACTIVE DECISION-MAKING AND FOSTER BETTER CARE COORDINATION 182
7.9 PATIENT ENGAGEMENT 183
7.9.1 PROACTIVE PATIENT ENGAGEMENT TO PROMOTE ADHERENCE TO
TREATMENT PLANS AND ENABLE TIMELY INTERVENTIONS 183
7.10 OTHER FUNCTIONS 184
8 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION 186
8.1 INTRODUCTION 187
8.2 PRIMARY CARE 187
8.2.1 TECHNOLOGICAL ADVANCEMENTS AND CONVENIENT ACCESS TO HEALTHCARE FACILITIES TO AID MARKET GROWTH 187
8.3 SPECIALTY CARE 188
8.3.1 TELERADIOLOGY 190
8.3.1.1 Rise of cloud-based imaging solutions and AI-driven radiology tools to boost segment growth 190
8.3.2 TELECARDIOLOGY 191
8.3.2.1 Integration of AI, cloud-based ECG monitoring, and wearable health devices to fuel segment growth 191
8.3.3 TELENEUROLOGY 192
8.3.3.1 High prevalence of neurological disorders and incorporation of AI into diagnostic tools to spur segment growth 192
 
8.3.4 DIABETES 193
8.3.4.1 Rise in consumer demand for more accessible and cost-effective healthcare services to augment market growth 193
8.3.5 RESPIRATORY DISORDERS 193
8.3.5.1 Increasing global prevalence of chronic respiratory conditions among older adults to fuel market growth 193
8.3.6 HYPERTENSION 194
8.3.6.1 Need for continuous monitoring and rise of remote care technologies to propel market growth 194
8.3.7 TELEDERMATOLOGY 195
8.3.7.1 High prevalence of skin cancer and dermatology-related diseases to augment segment growth 195
8.3.8 TELESTROKE 196
8.3.8.1 Rising incidence of stroke and increasing geriatric population to drive market 196
8.3.9 TELEPSYCHIATRY 197
8.3.9.1 Shortage of mental health practitioners and poor access to psychiatric care in rural areas to fuel market growth 197
8.3.10 OTHER SPECIALTY CARE APPLICATIONS 198
8.4 TELEICU 199
8.4.1 INCREASED EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF SPECIALISTS TO SUPPORT MARKET GROWTH 199
8.5 VIRTUAL SITTING & NURSING 200
8.5.1 INCREASING DEMAND FOR HOME-BASED HEALTHCARE SERVICES TO FUEL MARKET GROWTH 200
8.6 OTHER APPLICATIONS 201
9 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP 202
9.1 INTRODUCTION 203
9.2 PEDIATRICS 203
9.2.1 INCREASING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE FOR CHILDREN IN RURAL AREAS TO DRIVE MARKET 203
9.3 ADULTS 204
9.3.1 HIGH DEMAND FOR REMOTE ROUTINE CHECK-UPS AND CHRONIC DISEASE MANAGEMENT TO PROPEL MARKET GROWTH 204
9.4 GERIATRICS 205
9.4.1 RISING GERIATRIC POPULATION TO AUGMENT NEED FOR REMOTE MEDICAL CONSULTATIONS 205
10 TELEHEALTH & TELEMEDICINE MARKET, BY END USER 207
10.1 INTRODUCTION 208
10.2 HEALTHCARE PROVIDERS 208
10.2.1 HOSPITALS 210
10.2.1.1 Increasing demand for advanced and high-quality to drive market 210
 
10.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS 211
10.2.2.1 High preference, minimized patient downtime, and reduced hospital stay to augment segment growth 211
10.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES 212
10.2.3.1 Need for prolonged treatment for chronic diseases and preference for participatory and preventive care to drive segment 212
10.2.4 HOME HEALTHCARE 213
10.2.4.1 Rising prevalence of chronic diseases and need for cost-effective solutions to aid market growth 213
10.2.5 OTHER HEALTHCARE PROVIDERS 214
10.3 HEALTHCARE PAYERS 214
10.3.1 PUBLIC HEALTHCARE PAYERS 216
10.3.1.1 Increasing healthcare R&D investments and favorable policies to drive segment 216
10.3.2 PRIVATE HEALTHCARE PAYERS 217
10.3.2.1 Implementation of telehealth services for mental health issues and substance usage to drive segment 217
10.4 PATIENTS 217
10.4.1 RISING GERIATRIC POPULATION TO INCREASE FOCUS ON TELEHEALTH SERVICES FOR LONG-TERM CARE NEEDS 217
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 218
10.5.1 RISE OF VIRTUAL CONSULTATIONS AND TELEMEDICINE PLATFORMS TO INCREASE CLINICAL TRIALS WITHOUT REGIONAL BARRIERS 218
10.6 MEDTECH COMPANIES 219
10.6.1 INCREASED DEMAND FOR INNOVATIVE HEALTHCARE DEVICES FOR REMOTE DIAGNOSIS AND TREATMENT TO AID MARKET GROWTH 219
10.7 OTHER END USERS 220
11 TELEHEALTH & TELEMEDICINE MARKET, BY REGION 222
11.1 INTRODUCTION 223
11.2 NORTH AMERICA 223
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 223
11.2.2 US 231
11.2.2.1 US to dominate North American telehealth & telemedicine market during study period 231
11.2.3 CANADA 238
11.2.3.1 Push for digital health integration to drive higher adoption of telehealth services 238
11.3 EUROPE 244
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 251
11.3.2 GERMANY 252
11.3.2.1 Favorable government legislation for digitalized healthcare to spur market growth 252
 
11.3.3 UK 258
11.3.3.1 Increased government focus on digital health solutions to aid market growth 258
11.3.4 FRANCE 265
11.3.4.1 Strategic investments and government policy reforms to fuel uptake of digital medical devices for treatment 265
11.3.5 ITALY 272
11.3.5.1 Increased government healthcare investments to foster greater efficiency and accessibility in digital health solutions 272
11.3.6 SPAIN 279
11.3.6.1 Developed eHealth sector and increased adoption of wearable health tracking devices to augment market growth 279
11.3.7 REST OF EUROPE 285
11.4 ASIA PACIFIC 292
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 300
11.4.2 CHINA 300
11.4.2.1 Investments in digital healthcare solutions to drive market 300
11.4.3 JAPAN 307
11.4.3.1 Favorable legal revisions and advancements in video and audio communication to aid market growth 307
11.4.4 INDIA 314
11.4.4.1 Ongoing digital transformation initiatives through favorable government schemes to support market adoption 314
11.4.5 AUSTRALIA 321
11.4.5.1 Significant government investments in rural, remote, and specialist aged care services to fuel uptake 321
11.4.6 REST OF ASIA PACIFIC 328
11.5 LATIN AMERICA 334
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 335
11.5.2 BRAZIL 342
11.5.2.1 Increased availability of smartphones and improved internet connectivity to propel market growth 342
11.5.3 MEXICO 349
11.5.3.1 Regulatory improvements in telemedicine consultations to boost market growth 349
11.5.4 REST OF LATIN AMERICA 356
11.6 MIDDLE EAST & AFRICA 363
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 363
11.6.2 GCC COUNTRIES 370
11.6.2.1 Shortage of healthcare workforce to drive adoption of telehealth services 370
11.6.3 REST OF MIDDLE EAST & AFRICA 377
 
12 COMPETITIVE LANDSCAPE 384
12.1 INTRODUCTION 384
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 384
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
TELEHEALTH & TELEMEDICINE MARKET 385
12.3 REVENUE ANALYSIS, 2019–2023 387
12.4 MARKET SHARE ANALYSIS, 2023 389
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 392
12.5.1 STARS 392
12.5.2 EMERGING LEADERS 392
12.5.3 PERVASIVE PLAYERS 392
12.5.4 PARTICIPANTS 392
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 394
12.5.5.1 Company footprint 394
12.5.5.2 Region footprint 395
12.5.5.3 Function footprint 396
12.5.5.4 Application footprint 397
12.5.5.5 Component footprint 398
12.5.5.6 End-user footprint 399
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 400
12.6.1 PROGRESSIVE COMPANIES 400
12.6.2 RESPONSIVE COMPANIES 400
12.6.3 DYNAMIC COMPANIES 400
12.6.4 STARTING BLOCKS 400
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 402
12.6.5.1 Detailed list of key startups/SMEs 402
12.6.5.2 Competitive benchmarking of key startups/SMEs 402
12.7 COMPANY VALUATION & FINANCIAL METRICS 403
12.8 BRAND/SOFTWARE COMPARATIVE ANALYSIS 404
12.9 COMPETITIVE SCENARIO 405
12.9.1 PRODUCT LAUNCHES & APPROVALS 405
12.9.2 DEALS 406
12.9.3 EXPANSIONS 407
12.9.4 OTHER DEVELOPMENTS 407
13 COMPANY PROFILES 409
13.1 KEY PLAYERS 409
13.1.1 MEDTRONIC 409
13.1.1.1 Business overview 409
13.1.1.2 Products/Services/Solutions offered 410
13.1.1.3 Recent developments 412
13.1.1.3.1 Product launches & approvals 412
13.1.1.3.2 Deals 413
13.1.1.4 MnM view 414
13.1.1.4.1 Right to win 414
13.1.1.4.2 Strategic choices 414
13.1.1.4.3 Weaknesses & competitive threats 414
13.1.2 TELADOC HEALTH, INC. 415
13.1.2.1 Business overview 415
13.1.2.2 Products/Services/Solutions offered 416
13.1.2.3 Recent developments 417
13.1.2.3.1 Product launches & enhancements 417
13.1.2.3.2 Deals 418
13.1.2.4 MnM view 419
13.1.2.4.1 Right to win 419
13.1.2.4.2 Strategic choices 419
13.1.2.4.3 Weaknesses & competitive threats 419
13.1.3 CISCO SYSTEMS, INC. 420
13.1.3.1 Business overview 420
13.1.3.2 Products/Services/Solutions offered 421
13.1.3.3 MnM view 423
13.1.3.3.1 Right to win 423
13.1.3.3.2 Strategic choices 423
13.1.3.3.3 Weaknesses & competitive threats 423
13.1.4 KONINKLIJKE PHILIPS N.V. 424
13.1.4.1 Business overview 424
13.1.4.2 Products/Services/Solutions offered 425
13.1.4.3 Recent developments 428
13.1.4.3.1 Product launches & approvals 428
13.1.4.3.2 Deals 429
13.1.4.4 MnM view 431
13.1.4.4.1 Right to win 431
13.1.4.4.2 Strategic choices 431
13.1.4.4.3 Weaknesses & competitive threats 431
13.1.5 ZOOM COMMUNICATIONS, INC. 432
13.1.5.1 Business overview 432
13.1.5.2 Products/Services/Solutions offered 433
13.1.5.3 Recent developments 433
13.1.5.3.1 Deals 433
13.1.5.4 MnM view 434
13.1.5.4.1 Right to win 434
13.1.5.4.2 Strategic choices 434
13.1.5.4.3 Weaknesses & competitive threats 434
 
13.1.6 GE HEALTHCARE 435
13.1.6.1 Business overview 435
13.1.6.2 Products/Services/Solutions offered 436
13.1.6.3 Recent developments 438
13.1.6.3.1 Product launches & approvals 438
13.1.6.3.2 Deals 438
13.1.7 EPIC SYSTEMS CORPORATION 440
13.1.7.1 Business overview 440
13.1.7.2 Products/Services/Solutions offered 440
13.1.7.3 Recent developments 442
13.1.7.3.1 Product launches & enhancements 442
13.1.7.3.2 Deals 443
13.1.8 ORACLE 444
13.1.8.1 Business overview 444
13.1.8.2 Products/Services/Solutions offered 445
13.1.8.3 Recent developments 447
13.1.8.3.1 Product launches 447
13.1.8.3.2 Deals 447
13.1.9 DOXIMITY, INC. 450
13.1.9.1 Business overview 450
13.1.9.2 Products/Services/Solutions offered 451
13.1.9.3 Recent developments 452
13.1.9.3.1 Product enhancements 452
13.1.9.3.2 Deals 452
13.1.9.3.3 Other developments 453
13.1.10 AMERICAN WELL 454
13.1.10.1 Business overview 454
13.1.10.2 Products/Services/Solutions offered 455
13.1.10.3 Recent developments 456
13.1.10.3.1 Product launches 456
13.1.10.3.2 Deals 457
13.1.10.3.3 Other developments 457
13.1.11 SIEMENS HEALTHINEERS AG 458
13.1.11.1 Business overview 458
13.1.11.2 Products/Services/Solutions offered 459
13.1.11.3 Recent developments 461
13.1.11.3.1 Product launches & approvals 461
13.1.11.3.2 Deals 461
13.1.12 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.) 463
13.1.12.1 Business overview 463
13.1.12.2 Products/Services/Solutions offered 463
 
13.1.12.3 Recent developments 464
13.1.12.3.1 Deals 464
13.1.12.3.2 Other developments 465
13.1.13 AMC HEALTH 466
13.1.13.1 Business overview 466
13.1.13.2 Products/Services/Solutions offered 466
13.1.13.3 Recent developments 467
13.1.13.3.1 Deals 467
13.1.14 TELESPECIALISTS 468
13.1.14.1 Business overview 468
13.1.14.2 Products/Services/Solutions offered 468
13.1.14.3 Recent developments 469
13.1.14.3.1 Product launches 469
13.1.14.3.2 Deals 469
13.1.14.3.3 Other developments 469
13.1.15 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.) 470
13.1.15.1 Business overview 470
13.1.15.2 Products/Services/Solutions offered 471
13.1.15.3 Recent developments 471
13.1.15.3.1 Product launches 471
13.1.15.3.2 Deals 472
13.1.15.3.3 Expansions 472
13.1.16 CAREGILITY 473
13.1.16.1 Business overview 473
13.1.16.2 Products/Services/Solutions offered 473
13.1.16.3 Recent developments 474
13.1.16.3.1 Product launches 474
13.1.16.3.2 Deals 474
13.1.16.3.3 Other developments 475
13.1.17 CVS HEALTH 476
13.1.17.1 Business overview 476
13.1.17.2 Products/Services/Solutions offered 477
13.1.17.3 Recent developments 478
13.1.17.3.1 Product launches 478
13.1.17.3.2 Deals 478
13.1.18 EVERNORTH HEALTH, INC. 479
13.1.18.1 Business overview 479
13.1.18.2 Products/Services/Solutions offered 481
13.1.18.3 Recent developments 482
13.1.18.3.1 Deals 482
 
13.1.19 ELATION 483
13.1.19.1 Business overview 483
13.1.19.2 Products/Services/Solutions offered 483
13.1.19.3 Recent developments 483
13.1.19.3.1 Deals 483
13.1.20 IRON BOW TECHNOLOGIES 484
13.1.20.1 Business overview 484
13.1.20.2 Products/Services/Solutions offered 484
13.2 OTHER PLAYERS 486
13.2.1 TIMEDOC, INC. 486
13.2.2 CEREBRAL INC. 487
13.2.3 KINDBODY 488
13.2.4 TRANSCARENT 489
13.2.5 CARESIMPLE INC. 490
14 APPENDIX 491
14.1 DISCUSSION GUIDE 491
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 497
14.3 CUSTOMIZATION OPTIONS 499
14.4 RELATED REPORTS 499
14.5 AUTHOR DETAILS 500